Yale University and Boehringer Ingelheim Biomedical Data Science Fellowship Program

Yale University, in partnership with Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, launched in 2021 a Biomedical Data Science Fellowship program designed to attract and support some of the brightest and most innovative minds in data science from around the world.

The program has successfully offered ten competitive fellowships during its initial phase and will expand by recruiting three new fellows in 2025 and two in 2026. Post-doctoral researchers awarded a three-year fellowship will have access to Yale’s world class faculty, cutting edge research programs, various biomedical data repositories, and robust computational resources. Applicants with strong biomedical data science background and research experience are invited to submit research proposals for consideration. If approved for a fellowship, they will be jointly mentored throughout the research process by Yale’s faculty and scientists from Boehringer Ingelheim. In addition to receiving research funding and mentorship, program fellows will be invited to participate in campus and corporate visits, networking events, and annual symposia.

The program leverages the expertise of faculty and research members representing diverse disciplines from computational biology, bioinformatics, biomedical informatics, statistics, biostatistics, computer science, mathematics, biomedical engineering, systems biology, precision medicine, and public health informatics.